Ajooni Biotech Limited (AJOONI) — Cash Flow-to-Debt Ratio
Ajooni Biotech Limited (AJOONI) has a Cash Flow-to-Debt Ratio of 0.95x as of September 2025, meaning its operating cash flow of Rs135.46 Million could theoretically repay 1% of its total liabilities (Rs143.18 Million) in one year. See Ajooni Biotech Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ajooni Biotech Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Ajooni Biotech Limited across 13 annual periods. Also explore net asset growth rate of Ajooni Biotech Limited to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ajooni Biotech Limited (2013–2025)
Year-by-year debt coverage analysis for Ajooni Biotech Limited. For market capitalisation and broader financial context, see Ajooni Biotech Limited (AJOONI) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.54x | Rs-177.37 Million | Rs69.72 Million | ▼ -209.7% |
| 2024 | -0.82x | Rs-39.52 Million | Rs48.12 Million | ▼ -151.2% |
| 2023 | -0.33x | Rs-55.79 Million | Rs170.62 Million | ▼ -212.2% |
| 2022 | 0.29x | Rs36.84 Million | Rs126.35 Million | ▲ +212.2% |
| 2021 | 0.09x | Rs11.56 Million | Rs123.76 Million | ▲ +115.3% |
| 2020 | -0.61x | Rs-43.85 Million | Rs71.76 Million | ▲ +24.4% |
| 2019 | -0.81x | Rs-49.19 Million | Rs60.85 Million | ▼ -13265151475.7% |
| 2018 | 0.00x | Rs-0.51 | Rs83.70 Million | ▲ +100.0% |
| 2017 | -0.06x | Rs-6.69 Million | Rs118.86 Million | ▲ +82.6% |
| 2016 | -0.32x | Rs-6.15 Million | Rs19.06 Million | ▼ -330.1% |
| 2015 | 0.14x | Rs1.67 Million | Rs11.88 Million | ▲ +114.2% |
| 2014 | -0.99x | Rs-1.45 Million | Rs1.46 Million | ▲ +80.2% |
| 2013 | -5.00x | Rs-10.00K | Rs2.00K | — |